QUALITY AND BIOEQUIVALENCE GUIDELINE
Registration of Medicines Quality and Bioequivalence Guideline 2.02_Quality and Bioequivalence Guideline_Jul19_v7 Page 1 of 35 QUALITY AND BIOEQUIVALENCE GUIDELINE This guideline is intended to provide recommendations to applicants wishing to submit new registration applications as well as variations.
Tags:
Guidelines, Quality, Registration, Medicine, Bioequivalence, Quality and bioequivalence guideline, Registration of medicines quality and bioequivalence guideline
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Registration of Medicines Stability MEDICINES …
www.sahpra.org.zaRegistration of Medicines Stability 2.05_Stability_Jul12_v7_1 Page August 2012 1 of 27 MEDICINES CONTROL COUNCIL STABILITY This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of
MEDICINES CONTROL COUNCIL - sahpra.org.za
www.sahpra.org.zaRegistration of Medicines CMs DS Safety & Efficacy 7.01_CMs_SE_DS_Jun16_v3.doc June 2016 Page 1 of 46 MEDICINES CONTROL COUNCIL COMPLEMENTARY MEDICINES - DISCIPLINE-SPECIFIC
MEDICINES CONTROL COUNCIL - sahpra.org.za
www.sahpra.org.zaRegistration of Medicines Amendments . 2.08_Amendments_Jul12_v6_showing_changes August 2012 . Page 1 of 43. MEDICINES CONTROL COUNCIL . AMENDMENTS
Medicines Control Council - sahpra.org.za
www.sahpra.org.zaRegistration of Medicines Reporting of Adverse Drug Reactions 2.11_ADR_reporting_May03_v1_2.doc December 2012 Page 2 of 18 TABLE OF CONTENTS Page 1 Introduction 4
SOUTH AFRICAN HEALTH PRODUCTS …
www.sahpra.org.zawww.ursonline.co.za URS 24099 The South African Health Products Regulatory Authority (SAHPRA), is the National Medicines Regulatory Authority established in terms of the Medicines and Related Substances Act,
MEDICINES CONTROL COUNCIL - sahpra.org.za
www.sahpra.org.za6.01 MRF1 Medicine Registration Application (Human) - replaced by ZA-CTD . 6.02 MRF2 Screening of Application* 6.03 MRF4 Package Insert Amendments*
POLICY ON MANAGEMENT OF POTENTIAL …
www.sahpra.org.zaMEDICINES CONTROL COUNCIL POLICY ON MANAGEMENT OF POTENTIAL CONFLICT OF INTEREST NOVEMBER 2011. 1 INTRODUCTION. Section 6(4) of the Medicines and Related Substances Act 101 of 1965 “The ,
Government Gazette Staatskoerant - sahpra.org.za
www.sahpra.org.za"(z) the category of medicine immediately preceding the registration or application number; (aa) the pharmacological classification of the medicine; and
MEDICINES CONTROL COUNCIL - sahpra.org.za
www.sahpra.org.zaAnnex 12 Use of ionising radiation in the manufacture of medicinal products – cont. 12.5.1 . General : 96 . 12.5.2 : Gamma irradiators A Design . 96
MEDICINES CONTROL COUNCIL - sahpra.org.za
www.sahpra.org.zaThis document is intendedto serve as guidance on the requirements for Good Manufacturing Practice in South Africa. This guideline is not intended as an exclusive approach.
Related documents
Impurities in Drug Products and Drug Substances - A USP ...
latam-edu.usp.orgEach registration is unique and grants the right for ... • Elevated impurity levels observed during stability • Presence of undeclared drug ingredients • Contamination • Adulteration ... of over-the-counter medicines because of consumer complaints of a musty or moldy odor.
Blister packs FAQs for prescribers - PSNC Main site
psnc.org.uk• Medicines which are stored in the fridge eg fludrocortisone • Medicines intended for “as required” use eg analgesics, laxatives • Medicines that have special administration instructions and must be identified individually in order to do this safely e.g. alendronate Individual clinical assessment may override stability concerns.
Blister, Stability, Medicine, Pack, Faqs, Prescriber, Blister packs faqs for prescribers
Q 1 A (R2) Stability Testing of new Drug Substances and ...
www.ema.europa.eustability data package for a new drug substance or drug product that is sufficient for a registration application within the three regions of the EC, Japan, and the United States. It does not seek necessarily to cover the testing for registration in or export to other areas of the world.
Vaccine Rollout Framework and Plan: Immediate Actions
www.westerncape.gov.zao Medicines and Related Substances Act 101 of 1965 • Emergency procurement procedures for vaccine, service providers in logistics, training, communication, HR where no contracts are available. • Request deviation from NT for deviation from normal supply chain processes for vaccines • SAHPRA registration/approval required
Registration, Framework, Plan, Medicine, Vaccine, Rollout, Vaccine rollout framework and plan
Stability testing for prescription medicines
www.tga.gov.auStability testing for prescription medicines V1.1 March 2017 Page 10 of 20 . To determine whether contact with the container closure affects the container integrity and/or the stability of liquid medicines in containers (other than ampoules): provide the stability data conducted with the liquid medicine stored in the inverted position
M4 Step 5 CTD for the registration of pharmaceuticals for ...
www.ema.europa.euand compile different registration dossiers, this guideline describes a format for the Common Technical Document that will be acceptable in all three regions. Scope of the guideline This guideline primarily addresses the organisation of the information to be presented in registration
ICH guideline Q9 (R1) on quality risk management
www.ema.europa.euICH Q9(R1) Guideline 2 33 scenarios, so that appropriate risk control can be decided upon during technology transfer, for 34 use during the commercial manufacturing phase. In this context, knowledge is used to make 35 informed risk-based decisions, trigger re-evaluations and stimulate continual improvements. 36 Effective and proactive quality risk management can facilitate …